ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-0419

Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Zirve Information Technologies Inc.

Published Sep 17, 2025 · catalog updated Jun 6, 2026 · Zirve Information Technologies Inc. Zirve Nova

Last checked Oct 29, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-0419. EPSS is 0.24%. Act only if a listed version of Zirve Information Technologies Inc. Zirve Nova is installed.

Gaps on this record

  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium4.7
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.24%
Remediation
Vendor / distro source
Affected products
vendor Zirve Information Technologies Inc. Zirve Nova 235 ≤20250131

Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Zirve Information Technologies Inc. Zirve Nova allows Cross-Site Scripting (XSS). This issue affects Zirve Nova: from 235 through 20250131.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Zirve Information Technologies Inc. Zirve Nova 235 ≤20250131235 ≤20250131

How to fix CVE-2025-0419

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-0419. EPSS is 0.24%. Act only if a listed version of Zirve Information Technologies Inc. Zirve Nova is installed.

Which versions are affected?

Compare what you have installed with Zirve Information Technologies Inc. Zirve Nova 235 ≤20250131 235 ≤20250131. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.24%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Sep 17, 2025 · EUVD

    Detected

    Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Zirve Information Technologies Inc. Zirve Nova allows Cross-Site Scripting (XSS). This issue affects Zirve Nova: from 235 through 20250131.

  2. Jun 6, 2026 · EUVD

    Updated

    Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Zirve Information Technologies Inc. Zirve Nova allows Cross-Site Scripting (XSS). This issue affects Zirve Nova: from 235 through 20250131.

Sources

  • CVE.orgVulnerability recordCVE-2025-0419

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-0419

    30-day exploitation probability 0.24%

    first.org
  • EUVDVulnerability recordEUVD-2025-29701

    Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Zirve Information Technologies Inc. Zirve Nova allows Cross-Site Scripting (XSS). This issue affects Zirve Nova: from 235 through 20250131.

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 29, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • FIRST EPSSOct 23, 2026
  • CVE.orgOct 22, 2026
  • EUVDOct 22, 2026